After a brief intermission from awarding defense contracts Tuesday, the Department of Defense got back to the business of awarding work to America's defense contractors Wednesday -- with a vengeance. Over the course of 22 separate defense contract announcements Wednesday, the Pentagon awarded well over $5.18 billion in new work.
Most of the contracts awarded and monies earmarked went to the purchase of fuel for DoD aircraft -- most, but not all. Among the other contracts handed out:
- Johnson & Johnson (NYSE:JNJ) subsidiary Janssen Pharmaceuticals won $41.4 million for the second of seven possible one-year-long option exercises on a contract to supply "various pharmaceutical products" to the U.S. Army, Navy, Air Force, and Marine Corps through Dec. 15, 2014.
- EMCOR (NYSE:EME) was awarded a $30.8 million option exercise to support operations at the following regional locations: Naval Support Activity Washington, Naval Support Activity Bethesda, Naval Support Activity South Potomac, and Quantico Marine Corp Base. EMCOR will be responsible for performing repair and maintenance of property, facilities, and assets at these locations through December 2014. This modification increases the total value of EMCOR's contract to more than $198 million.
- Exelis (UNKNOWN:XLS.DL) subsidiary EDO won a $10.2 million sole-source, indefinite-delivery/indefinite-quantity requirements contract to repair ALQ-161 radio frequency surveillance/electronic countermeasure (RFS/ECM) system components used aboard Air Force B-1 strategic bombers through Dec. 5, 2014.
- Northrop Grumman (NYSE:NOC) was awarded a $7.7 million contract modification for work on the Intercontinental Ballistic Missile Remote Visual Assessment (RVA) Wing III Retrofit program. Northrop will perform maintenance on Launch Control Center RVA feeds, closed circuit television systems, flight security controllers, and all supporting equipment. Its work should be complete by Sept. 30, 2014.
Fool contributor Rich Smith has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson and owns shares of Johnson & Johnson and Northrop Grumman. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.